PTC Therapeutics, Inc. (PTCT)
71.02
+1.20
(+1.72%)
USD |
NASDAQ |
Aug 24, 16:00
71.02
0.00 (0.00%)
After-Hours: 20:00
PTC Therapeutics Debt to Equity Ratio : -4.212 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.212 |
| March 31, 2026 | -2.189 |
| December 31, 2025 | -1.942 |
| September 30, 2025 | -2.633 |
| June 30, 2025 | -1.879 |
| March 31, 2025 | -2.097 |
| December 31, 2024 | -0.3545 |
| September 30, 2024 | -0.3796 |
| June 30, 2024 | -0.4035 |
| March 31, 2024 | -0.4715 |
| December 31, 2023 | -0.507 |
| September 30, 2023 | -1.05 |
| June 30, 2023 | -1.213 |
| March 31, 2023 | -1.532 |
| December 31, 2022 | -2.027 |
| September 30, 2022 | -1.829 |
| June 30, 2022 | -3.290 |
| March 31, 2022 | -5.875 |
| December 31, 2021 | 372.31 |
| September 30, 2021 | 12.00 |
| June 30, 2021 | 6.336 |
| March 31, 2021 | 4.211 |
| December 31, 2020 | 0.8723 |
| September 30, 2020 | 2.111 |
| June 30, 2020 | 0.6497 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.6294 |
| December 31, 2019 | 0.5519 |
| September 30, 2019 | 0.493 |
| June 30, 2019 | 0.3402 |
| March 31, 2019 | 0.3235 |
| December 31, 2018 | 0.4363 |
| September 30, 2018 | 0.3909 |
| June 30, 2018 | 0.5567 |
| March 31, 2018 | 0.9772 |
| December 31, 2017 | 0.9267 |
| September 30, 2017 | 0.9809 |
| June 30, 2017 | 0.8322 |
| March 31, 2017 | 0.9908 |
| December 31, 2016 | 0.8213 |
| September 30, 2016 | 0.6888 |
| June 30, 2016 | 0.5732 |
| March 31, 2016 | 0.4764 |
| December 31, 2015 | 0.4186 |
| September 30, 2015 | 0.3463 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Insmed, Inc. | 0.9865 |
| Madrigal Pharmaceuticals, Inc. | 0.664 |
| Protagonist Therapeutics, Inc. | 0.011 |
| Biogen, Inc. | 0.4433 |
| BioMarin Pharmaceutical, Inc. | 0.6672 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 3.250B |
| Total Liabilities (Quarterly) | 3.416B |
| Shareholders Equity (Quarterly) | -165.36M |
| Current Ratio | 3.394 |
| Net Debt Paydown Yield | -0.90% |